Cholesterol-Lowering Medication Recommendations for Older Adults with Statin Allergy
Primary Recommendation: Ezetimibe
- The American College of Cardiology recommends starting ezetimibe 10 mg daily as the first-line cholesterol-lowering medication for patients with statin intolerance, due to its demonstrated safety, tolerability, and convenience 1
Second-Line Options if Ezetimibe is Insufficient
- The American College of Cardiology suggests considering bile acid sequestrants, such as colesevelam, if LDL cholesterol targets are not achieved with ezetimibe alone, but only if fasting triglycerides are ≤300 mg/dL, as noted in the ACC/AHA guidelines 2, 3, 4
- The American College of Cardiology recommends reserving PCSK9 inhibitors for patients who fail to achieve adequate LDL reduction with ezetimibe, particularly those with very high cardiovascular risk, established atherosclerotic disease, or heterozygous familial hypercholesterolemia 5, 6, 7
Important Clinical Considerations for Age 75
- The American College of Cardiology guidelines recommend continuing to consider overall cardiovascular risk, life expectancy, frailty status, and patient preferences when deciding to treat with alternative therapy in patients over 75 with established cardiovascular disease and a true statin allergy 5
Common Pitfalls to Avoid
- The American College of Cardiology advises against skipping directly to PCSK9 inhibitors, as most patients achieve adequate LDL reduction with ezetimibe, making it the cost-effective and evidence-based first choice 6
- The American College of Cardiology warns against using bile acid sequestrants if triglycerides >300 mg/dL, as this can worsen hypertriglyceridemia 2, 1